IDXX vs ITRM · P/E 40, rev $2.36B vs rev $390.0K
IDEXX Laboratories Inc (IDXX) versus Iterum Therapeutics PLC (ITRM) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. ITRM currently screens at market cap $38.6M.
Not investment advice. Open the IDXX and ITRM stock pages for the full models.
Not investment advice.